Lerato Majara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lerato Majara has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Alicia R. Martin
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
4 shared publications - Elizabeth G. Atkinson
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA
3 shared publications Nastassja Koen
Department of Psychiatry and Mental Health, University of Cape Town
3 shared publicationsAbebaw Fekadu
Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University
2 shared publications- Allan Kalungi
Medical Research Council, Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI &LSHTM), Entebbe, Uganda
2 shared publications - Anne Stevenson
Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2 shared publications
Latest Publications
- Open Access
A blended genome and exome sequencing method captures genetic variation in an unbiased, high-quality, and cost-effective manner
We deployed the Blended Genome Exome (BGE), a DNA library blending approach that generates low pass whole genome (1-4x mean depth) and deep whole exome (30-40x mean depth) data in a single sequencing run. This technology is cost-effective, empowers most genomic discoveries possible with deep whole genome sequencing, and provides an unbiased method to capture the diversity of common SNP variation across the globe. To evaluate this new technology at scale, we applied BGE to sequence >53,000 samples from the Populations Underrepresented in Mental Illness Associations Studies (PUMAS) Project, which included participants across African, African American, and Latin American populations. We evaluated the accuracy of BGE imputed genotypes against raw genotype calls from the Illumina Global Screening Array. All PUMAS cohorts had R 2 concordance ≥95% among SNPs with MAF≥1%, and never fell below ≥90% R 2 for SNPs with MAF<1%. Furthermore, concordance rates among local ancestries within two recently admixed cohorts were consistent among SNPs with MAF≥1%, with only minor deviations in SNPs with MAF<1%. We also benchmarked the discovery capacity of BGE to access protein-coding copy number variants (CNVs) against deep whole genome data, finding that deletions and duplications spanning at least 3 exons had a positive predicted value of ∼90%. Our results demonstrate BGE scalability and efficacy in capturing SNPs, indels, and CNVs in the human genome at 28% of the cost of deep whole-genome sequencing. BGE is poised to enhance access to genomic testing and empower genomic discoveries, particularly in underrepresented populations.
Open AccessA blended genome and exome sequencing method captures genetic variation in an unbiased, high-quality, and cost-effective manner
We deployed the Blended Genome Exome (BGE), a DNA library blending approach that generates low pass whole genome (1-4x mean depth) and deep whole exome (30-40x mean depth) data in a single sequencing run. This technology is cost-effective, empowers most genomic discoveries possible with deep whole genome sequencing, and provides an unbiased method to capture the diversity of common SNP variation across the globe. To evaluate this new technology at scale, we applied BGE to sequence >53,000 samples from the Populations Underrepresented in Mental Illness Associations Studies (PUMAS) Project, which included participants across African, African American, and Latin American populations. We evaluated the accuracy of BGE imputed genotypes against raw genotype calls from the Illumina Global Screening Array. All PUMAS cohorts had R 2 concordance ≥95% among SNPs with MAF≥1%, and never fell below ≥90% R 2 for SNPs with MAF<1%. Furthermore, concordance rates among local ancestries within two recently admixed cohorts were consistent among SNPs with MAF≥1%, with only minor deviations in SNPs with MAF<1%. We also benchmarked the discovery capacity of BGE to access protein-coding copy number variants (CNVs) against deep whole genome data, finding that deletions and duplications spanning at least 3 exons had a positive predicted value of ∼90%. Our results demonstrate BGE scalability and efficacy in capturing SNPs, indels, and CNVs in the human genome at 28% of the cost of deep whole-genome sequencing. BGE is poised to enhance access to genomic testing and empower genomic discoveries, particularly in underrepresented populations.
- Open Access
- 13 February 2023
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 4 (2) , 100184
Low and differential polygenic score generalizability among African populations due largely to genetic diversity
- 13 February 2023
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 4 (2) , 100184
Open AccessLow and differential polygenic score generalizability among African populations due largely to genetic diversity
- Open Access
- 1 September 2022
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 109 (9) , 1667-1679
Genetic structure correlates with ethnolinguistic diversity in eastern and southern Africa
- 1 September 2022
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 109 (9) , 1667-1679
Open AccessGenetic structure correlates with ethnolinguistic diversity in eastern and southern Africa
- Open Access
Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity
Summary: Asthma is a complex disease that affects millions of people and varies in prevalence by an order of magnitude across geographic regions and populations. However, the extent to which genetic variation contributes to these disparities is unclear, as studies probing the genetics of asthma have been primarily limited to populations of European (EUR) descent. As part of the Global Biobank Meta-analysis Initiative (GBMI), we conducted the largest genome-wide association study of asthma to date (153,763 cases and 1,647,022 controls) via meta-analysis across 18 biobanks spanning multiple countries and ancestries. Altogether, we discovered 179 genome-wide significant loci (p < 5×10 −8 ) associated with asthma, 49 of which are not previously reported. We replicate well-known associations such as IL1RL1 and STAT6 , and find that overall the novel associations have smaller effects than previously-discovered loci, highlighting our substantial increase in statistical power. Despite the considerable range in prevalence of asthma among biobanks, from 3% to 24%, the genetic effects of associated loci are largely consistent across the biobanks and ancestries. To further investigate the polygenic architecture of asthma, we construct polygenic risk scores (PRS) using a multi-ancestry approach, which yields higher predictive power for asthma in non-EUR populations compared to PRS derived from previous asthma meta-analyses. Additionally, we find considerable genetic overlap between asthma age-of-onset subtypes, as well as between asthma and chronic obstructive pulmonary disease (COPD) but minimal overlap in enriched biological pathways. Our work underscores the multifactorial nature of asthma development and offers insight into the shared genetic architecture of asthma that may be differentially perturbed by environmental factors and contribute to variation in prevalence.
Open AccessMulti-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity
Summary: Asthma is a complex disease that affects millions of people and varies in prevalence by an order of magnitude across geographic regions and populations. However, the extent to which genetic variation contributes to these disparities is unclear, as studies probing the genetics of asthma have been primarily limited to populations of European (EUR) descent. As part of the Global Biobank Meta-analysis Initiative (GBMI), we conducted the largest genome-wide association study of asthma to date (153,763 cases and 1,647,022 controls) via meta-analysis across 18 biobanks spanning multiple countries and ancestries. Altogether, we discovered 179 genome-wide significant loci (p < 5×10 −8 ) associated with asthma, 49 of which are not previously reported. We replicate well-known associations such as IL1RL1 and STAT6 , and find that overall the novel associations have smaller effects than previously-discovered loci, highlighting our substantial increase in statistical power. Despite the considerable range in prevalence of asthma among biobanks, from 3% to 24%, the genetic effects of associated loci are largely consistent across the biobanks and ancestries. To further investigate the polygenic architecture of asthma, we construct polygenic risk scores (PRS) using a multi-ancestry approach, which yields higher predictive power for asthma in non-EUR populations compared to PRS derived from previous asthma meta-analyses. Additionally, we find considerable genetic overlap between asthma age-of-onset subtypes, as well as between asthma and chronic obstructive pulmonary disease (COPD) but minimal overlap in enriched biological pathways. Our work underscores the multifactorial nature of asthma development and offers insight into the shared genetic architecture of asthma that may be differentially perturbed by environmental factors and contribute to variation in prevalence.